Biosceptre

Develops immunotherapies for oncology

placeCambridge, England, United Kingdom calendar_todayFounded 2000 groups10 employees language biosceptre.com

Registered entities

Social engagement

Social engagement: 2.6K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

43 investors on record; lead investors include Tuspark.

Investor typeCountShare
Venture capital12%
Private equity12%
Accelerator & incubator25%
Other / undisclosed3991%

Recent activity

2 Feb 2026
Event
ANZ BIOLOGICS FESTIVAL 2026
Coming soon